Renaissance Technologies - XTL BIOPHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 6 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of XTL BIOPHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2021$64,000
-34.7%
23,280
+4.5%
0.00%–
Q3 2021$98,000
-33.8%
22,280
-40.1%
0.00%–
Q2 2021$148,000
+14.7%
37,187
-4.2%
0.00%–
Q1 2021$129,000
+118.6%
38,800
+98.7%
0.00%–
Q4 2020$59,000–19,531–0.00%–
 Download
Other shareholders
XTL BIOPHARMACEUTICALS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Noked Capital LTD 198,888$794,0000.20%
Noked Israel Ltd 198,888$794,0000.20%
SteelPeak Wealth, LLC 11,671$47,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 54,064$216,0000.00%
Renaissance Technologies 37,187$148,0000.00%
View complete list of XTL BIOPHARMACEUTICALS LTD shareholders